tiprankstipranks
Trending News
More News >
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
US Market
Advertisement

Monte Rosa Therapeutics (GLUE) Ownership - Who Owns Monte Rosa Therapeutics?

Compare
299 Followers

Monte Rosa Therapeutics (GLUE) Ownership Overview

22.88%20.32%0.02%9.90%46.88%
22.88% Insiders
0.02% Other Institutional Investors
9.90% ETFs
46.88% Public Companies and
Individual Investors
The ownership structure of Monte Rosa Therapeutics (GLUE) stock is a mix of institutional, retail, and individual investors. Approximately 30.24% of the company’s stock is owned by Institutional Investors, 22.88% is owned by Insiders, and 46.88% is owned by Public Companies and Individual Investors.
The ownership structure of Monte Rosa Therapeutics (GLUE) stock is a mix of institutional, retail, and individual investors. Approximately 20.34% of the company’s stock is owned by Institutional Investors, 22.88% is owned by Insiders, and 9.90% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 04, 2025
xxxxxxxxxxxxx
$9155
Mar 25, 2025
xxxxxxxxxxxxx
$58300
Oct 30, 2024
xxxxxxxxxxxxx
$1489973
Sep 24, 2024
xxxxxxxxxxxxx
$7384330

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$151199
Mar 31, 2025
xxxxxxxxxxxxx
$6831615

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
7,692,298Insider12.51%45,384,558
5,652,922Institution9.19%33,352,240
5,652,922Insider9.19%33,352,240
4,916,095Institution7.99%29,004,961
3,227,172Institution5.25%19,040,315
3,036,264Institution4.94%17,913,958
2,646,354Institution4.30%15,613,489
2,114,970Institution3.44%12,478,323
1,556,006Institution2.53%9,180,435
1,472,331Institution2.39%8,686,753

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,227,172Institution5.25%19,040,315
2,646,354Institution4.30%15,613,489
1,556,006Institution2.53%9,180,435
1,011,007Institution1.64%5,964,941
918,375Institution1.49%5,418,413
540,520Institution0.88%3,189,068
536,436Institution0.87%3,164,972
476,806Institution0.78%2,813,155
448,150Institution0.73%2,644,085
220,299Institution0.36%1,299,764

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,921,301Institution3.12%8,665,068
1,138,956Institution1.85%6,719,840
717,730Institution1.17%3,236,962
399,462Institution0.65%2,356,826
279,137Institution0.45%1,646,908
237,429Institution0.39%1,070,805
222,253Institution0.36%1,246,839
203,119Institution0.33%1,139,498
125,583Institution0.20%566,379
116,830Institution0.19%655,416

FAQ

Who Owns Monte Rosa Therapeutics (GLUE)?
According to the latest TipRanks data, approximately 0.02% of the company's stock is held by institutional investors, 22.88% is held by insiders, and 46.88% is held by retail investors.
    What percentage of Monte Rosa Therapeutics (GLUE) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.02% of Monte Rosa Therapeutics (GLUE) stock is held by institutional investors.
      What percentage of Monte Rosa Therapeutics (GLUE) stock is held by retail investors?
      According to the latest TipRanks data, approximately 46.88% of Monte Rosa Therapeutics (GLUE) stock is held by retail investors.
        Who owns the most shares of Monte Rosa Therapeutics (GLUE)?
        Ali Behbahani owns the most shares of Monte Rosa Therapeutics (GLUE).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis